Xylem (NYSE:XYL) Stock Analysis: Goldman Sachs Reiterates Buy Amidst Mixed Q3 Earnings
Goldman Sachs maintains a Buy rating for Xylem (NYSE:XYL), setting a price target significantly above the current share price. The company reported mixed third-quarter 2026 results, with adjusted earnings per share missing consensus estimates despite a year-over-year increase, and revenue also…